Cargando…
Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens
Microbial Multidrug Resistance (MDR) is an emerging global crisis. Derivatization of natural or synthetic scaffolds is among the most reliable strategies to search for and obtain novel antimicrobial agents for the treatment of MDR infections. Here, we successfully manipulated the synthetically flexi...
Autores principales: | Al-Warhi, Tarfah, Elimam, Diaaeldin M., Elsayed, Zainab M., Abdel-Aziz, Marwa M., Maklad, Raed M., Al-Karmalawy, Ahmed A., Afarinkia, Kamyar, Abourehab, Mohammed A. S., Abdel-Aziz, Hatem A., Eldehna, Wagdy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629177/ https://www.ncbi.nlm.nih.gov/pubmed/36382148 http://dx.doi.org/10.1039/d2ra04385h |
Ejemplares similares
-
Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms
por: Eldehna, Wagdy M., et al.
Publicado: (2022) -
Identification of 3-(piperazinylmethyl)benzofuran derivatives as novel type II CDK2 inhibitors: design, synthesis, biological evaluation, and in silico insights
por: Eldehna, Wagdy M., et al.
Publicado: (2022) -
Development of Novel Isatin-Tethered Quinolines as Anti-Tubercular Agents against Multi and Extensively Drug-Resistant Mycobacterium tuberculosis
por: Abdelrahman, Mohamed A., et al.
Publicado: (2022) -
Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing–bacteria
por: Elsayed, Zainab M., et al.
Publicado: (2021) -
Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer
por: Eldehna, Wagdy M., et al.
Publicado: (2021)